Health In Tech financials
$0.8525−3.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 |
|---|---|---|---|---|---|---|---|
| Revenue | $8.1M | $8.8M | $7.5M | $8.5M | $9.3M | $8.0M | $4.9M |
| Gross profit | $3.9M | $4.5M | $4.1M | $5.1M | $6.3M | $5.4M | $3.8M |
| Gross margin | 48.7% | 51.4% | 55.0% | 60.6% | 67.7% | 66.8% | 77.4% |
| Operating income | -$3.4M | -$2.2M | -$170.8K | $493.5K | $725.1K | $480.7K | -$316.3K |
| Net income | -$2.5M | -$1.6M | -$302.6K | $452.2K | $630.6K | $498.6K | -$144.2K |
| Net margin | −31.2% | −18.1% | −4.0% | 5.3% | 6.8% | 6.2% | −2.9% |
| Diluted EPS | $-0.04 | $-0.03 | $-0.01 | $0.01 | $0.01 | $0.01 | $0.00 |
| EBITDA | -$3.1M | -$1.8M | $239.8K | $711.5K | $861.1K | $616.6K | -$180.4K |
| Operating cash flow | -$2.9M | -$3.3M | $451.2K | $674.0K | $1.5M | $527.4K | -$531.2K |
| Free cash flow | -$2.9M | -$3.3M | $451.2K | $674.0K | $1.5M | $527.4K | -$531.2K |
| Diluted shares | 62.8M | 57.4M | 59.6M | 58.8M | 55.6M | 57.0M | 59.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $6.5M | $10.3M | $7.7M | $8.0M | $8.1M | $7.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $29.6M | $29.0M | $23.1M | $22.8M | $22.2M | $21.3M |
| Total liabilities | $10.0M | $7.4M | $6.0M | $5.6M | $5.8M | $7.2M |
| Shareholders' equity | $19.6M | $21.6M | $17.1M | $17.2M | $16.4M | $14.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology